Kexxtone - direct healthcare professional communication (DHPC)

monensin (as monensin sodium)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct animal healthcare professional communication (DaHPC) : Kexxtone 32.4 g continuous-release intraruminal device for cattle (monensin): marketing authorisation suspension and market recall of all batches

Dissemination date: 05/06/2024

Key facts

• Medicine name:
  Kexxtone
• Active substance:
  monensin (as monensin sodium)
• Procedure number:
  EMEA/V/C/002235
• Regulatory outcome:
  Suspension
• DHPC type:
  Quality defect
• Referral name:
  Kexxtone 32.4 g continuous-release intraruminal device for cattle
• Veterinary ATC codes:
  QA16QA06
• Species:
  Cattle
• Dissemination date:
  05/06/2024
• Related medicines:
  Kexxtone 32.4 g continuous-release intraruminal device for cattle